Australian health stocks extend decline in CSL-led rout
** Australian health stocks .AXHJ fall 2.8% to 22,402 points ** Sub-index on track to extend losses for a sixth consecutive session, if current trend holds ** CSL CSL.AX, a major constituent of the sub-index, has lost more than 10% since Monday when it trimmed its annual profit forecast and flagged $5 billion impairment across 2026-2027 ** YTD, AXHJ down 33.6%, in tandem with a 0.7% drop in benchmark AXJO .AXJO (Reporting by Jasmeen Ara Shaikh in Bengaluru) ((Jasmeenaraislam.Shaikh@thomsonreuters.com;))
Recent news on Csl
See all newsEU Commission opens antitrust probe into Sanofi's flu vaccine campaign (updated)
EU Commission opens antitrust probe into Sanofi's flu vaccine campaign
Analysis: US prices for new drugs fell in 2025 as fewer costly gene therapies were launched
US military requires flu vaccine for some after outbreak in Texas training center
Corrected: BUZZ-Australian healthcare stocks hit a six-week high, acting as a primary hedge on ASX